Literature DB >> 19107352

Preparation and identification of scFv and bsFv against transferrin receptor.

Jing Liu1, Daiwen Xiao, Xiaoou Zhou, Xue Wen, Hong Dai, Zhihua Wang, Xin Shen, Wei Dai, Daofeng Yang, Guanxin Shen.   

Abstract

To obtain single chain variable fragment (scFv) and bivalent single chain variable fragment (bsFv) against transferrin receptor, up-stream and down-stream primers were designed according to the complementary sequences of FR1 region of variable heavy (VH) and FR4 of variable light (VL), respectively, which contained inter-linker G4S and the restriction endonuclease SfiI, AscI and NotI. Two pieces of scFv fragments were first amplified through PCR and then inserted into plasmid pAB1, which could express scFv protein once induced by IPTG in the host bacteria. To express scFv and bsFv, E. coli TG1 was cultured in LB broth and was induced by IPTG. The restriction enzyme digestion map and DNA sequencing demonstrated that scFv and bsFv genes were successfully inserted into the expression plasmid. SDS-PAGE and Western blotting revealed the protein band at 35kD and 60kD, which were consistent with the molecular weight of scFv and bsFv respectively. Flow cytometry showed that scFv and bsFv harbored the specific binding activity with TfR expressed in various tumor cells, and the avidity of bsFv was higher than that of the parent scFv.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19107352     DOI: 10.1007/s11596-008-0601-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

1.  Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies.

Authors:  T Takubo; T Kumura; T Nakao; H Nakamae; Y Aoyama; S Nishiki; Y Kinoshita; K R Koh; K Ohta; T Yamane; M Hino; T Kamitani; N Tatsumi
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

2.  The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.

Authors:  Ye Qing; Wang Shuo; Wang Zhihua; Zhu Huifen; Lei Ping; Liu Lijiang; Zhao Xiaorong; Chao Liming; Xiao Daiwen; Huang Yu; Xing Wei; Fang Min; Feng Zuohua; Shen Guanxin
Journal:  Cancer Immunol Immunother       Date:  2005-12-08       Impact factor: 6.968

3.  Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.

Authors:  D C Yang; F Wang; R L Elliott; J F Head
Journal:  Anticancer Res       Date:  2001 Jan-Feb       Impact factor: 2.480

4.  Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein.

Authors:  J Bhatia; S K Sharma; K A Chester; R B Pedley; R W Boden; D A Read; G M Boxer; N P Michael; R H Begent
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

5.  A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.

Authors:  Tsuneaki Asai; Ryan Trinh; Patrick P Ng; Manuel L Penichet; Letitia A Wims; Sherie L Morrison
Journal:  Biomol Eng       Date:  2004-12-09

Review 6.  Mechanism and clinical significance of soluble hepatic cell-surface receptors.

Authors:  Y Kohgo; H Kondo; Y Mogi; Y Niitsu
Journal:  Targeted Diagn Ther       Date:  1991

7.  Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer.

Authors:  I Bièche; M Olivi; M H Champème; D Vidaud; R Lidereau; M Vidaud
Journal:  Int J Cancer       Date:  1998-11-23       Impact factor: 7.396

8.  Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.

Authors:  José A Rodríguez; Gustavo Helguera; Tracy R Daniels; Isabel I Neacato; Héctor E López-Valdés; Andrew C Charles; Manuel L Penichet
Journal:  J Control Release       Date:  2007-08-25       Impact factor: 9.776

9.  Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation.

Authors:  Ping Lei; Yong He; Qing Ye; Hui-Fen Zhu; Xiao-Mei Yuan; Jing Liu; Wei Xing; Sha Wu; Wei Dai; Xin Shen; Guo-Bin Wang; Guan-Xin Shen
Journal:  Acta Pharmacol Sin       Date:  2007-10       Impact factor: 6.150

10.  The transferrin receptor: a potential molecular imaging marker for human cancer.

Authors:  Dagmar Högemann-Savellano; Erik Bos; Cyrille Blondet; Fuminori Sato; Tatsuya Abe; Lee Josephson; Ralph Weissleder; Justin Gaudet; Dennis Sgroi; Peter J Peters; James P Basilion
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

View more
  1 in total

1.  Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.

Authors:  Qing Ye; Heyu Hu; Zhihua Wang; Tong Lu; Zhiquan Hu; Xing Zeng; Shu Zhang; Jing Liu; Ping Lei; Cong-Yi Wang; Zhangqun Ye; Guanxin Shen
Journal:  BMC Biotechnol       Date:  2012-11-28       Impact factor: 2.563

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.